Heterocyclic compounds having anti-diabetic activity, their preparation and their use
申请人:SANKYO COMPANY LIMITED
公开号:EP0676398A2
公开(公告)日:1995-10-11
Compounds of formula (I) :
[wherein: X represents an unsubstituted or substituted indolyl, indolinyl, azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrimidinyl group ; Y represents an oxygen or sulphur atom ; Z represents a 2,4-dioxothiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group ; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group ; and m is an integer of from 1 to 5] have hypoglycemic and anti-diabetic activities.
式(I)化合物:
其中X 代表未取代或取代的吲哚基、吲哚啉基、氮杂吲哚啉基、咪唑吡啶基或咪唑嘧啶基; Y 代表氧原子或硫原子;Z 代表 2,4-二氧代噻唑啉-5-亚甲基、2,4-二氧代噻唑啉-5-基甲基、2,4-二氧代恶唑啉-5-基甲基、3,5-二氧代恶唑啉-2-基甲基或 N-羟基脲基甲基;R 代表氢原子、烷基、烷氧基、卤素原子、羟基、硝基、芳烷基或未取代或取代的氨基;以及 m 是 1 至 5 的整数]具有降血糖和抗糖尿病活性。